Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Traxi Panniculus Retractor for Cesarean Delivery

NCT: NCT03651076 · TERMINATED

NCT IDNCT03651076
StatusTERMINATED
Start Date2018-10-02
Completion2025-02-01
SponsorBeth Israel Deaconess Medical Center (OTHER)
First posted
Last updated

Brief Summary

This prospective, open-label, randomized-controlled trial is designed to evaluate the use of the Traxi panniculus retractor-- a commercially available Class I FDA-exempt device will improve surgical outcomes, cardiopulmonary function, and provider/patient satisfaction in morbidly obese women undergoing cesarean delivery.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑